Following genetic diagnosis, this population of 187 women with BRCA1/2 P/LP variants was faced with the need to choose the preventive option for breast cancer, with 50 (26.7%) women choosing RRM and 137 (73.3%) women opting for IBS. The gene discussed is BRCA1; the disease is irritable bowel syndrome.